Supplement Industry Must Step Up As Adulteration Threat Grows – FDA

The supplement industry has not done enough to aid FDA in pursuing firms adulterating products with drugs or getting the message out about adulteration, the agency says. Increased vigilance is needed especially as bad actors become more sophisticated and expand their adulteration activities.

More from United States

More from North America